MM-22
|
- $220 - $1260
- Product name: MM-22
- CAS: 956605-71-3
- MF: C36H60N4O5S
- MW: 660.95
- EINECS:
- MDL Number:MFCD22683803
- Synonyms:MM-22;(3aS,4S,6aR)-Hexahydro-2-oxo-N-[2-[2-[2-[[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl]amino]ethoxy]ethoxy]ethyl]-1H-thieno[3,4-d]imidazole-4-pentanamide;MM22,MM 22;1H-Thieno[3,4-d]imidazole-4-pentanamide, hexahydro-2-oxo-N-[2-[2-[2-[[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl]amino]ethoxy]ethoxy]ethyl]-, (3aS,4S,6aR)-
4 prices
Selected condition：
Brand
- ApexBio Technology
- TRC
- Usbiological
Package
- 1mg
- 2.5mg
- 10mg
- 50mg
- ManufacturerApexBio Technology
- Product numberB5527
- Product descriptionMM-22
- Packaging10mg
- Price$299
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB5527
- Product descriptionMM-22
- Packaging50mg
- Price$1260
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM425480
- Product descriptionMM-22
- Packaging2.5mg
- Price$220
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number456393
- Product descriptionMM-22
- Packaging1mg
- Price$382
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| ApexBio Technology | B5527 | MM-22 | 10mg | $299 | 2021-12-16 | Buy |
| ApexBio Technology | B5527 | MM-22 | 50mg | $1260 | 2021-12-16 | Buy |
| TRC | M425480 | MM-22 | 2.5mg | $220 | 2021-12-16 | Buy |
| Usbiological | 456393 | MM-22 | 1mg | $382 | 2021-12-16 | Buy |
Properties
Boiling point :870.6±65.0 °C(Predicted)
Density :1.055±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Soluble to 100 mM in DMSO and to 50 mM in ethanol
form :Powder
pka :13.90±0.40(Predicted)
Density :1.055±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Soluble to 100 mM in DMSO and to 50 mM in ethanol
form :Powder
pka :13.90±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|